BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and answer session, Tuesday, April 24, 2012. During the call, management will discuss the Company’s financial results for the first quarter ending March 31, 2012 and progress regarding its key value drivers - the KALBITOR® (ecallantide) business and angioedema franchise, as well as the Licensing and Funded Research Program (LFRP).
